News
June 01, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced today that the first patient has been dosed in the Phase ... in our CKD trial, marking an important initial step ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback